European Companies Search Engine
EU funding (€6,478,738): Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) Hor15 Dec 2016 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "ALBUTEC GmbH - EU funding (€6,478,738): Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.